The process of complex coacervation keeps viruses in vaccine solutions stable by crowding them tightly together, reducing the need for refrigeration.
Graphic Credit: Caryn Heldt and Sarah Perry
Half of vaccines are wasted annually because they aren’t kept cold. Chemical engineers have discovered a way to stabilize viruses in vaccines with proteins instead of temperature.
Ever receive a vaccination that seemed to burn while it was injected? The vaccine solution likely contained a lot of salt or sugar — natural preservatives that help keep it stable, in addition to the cold temperature at which it was kept.
The viruses in vaccines, which train our cells to identify and vanquish viral invaders, must be kept cold to keep them from bursting apart. The typical shipping temperature for vaccines ranges from 2 to 8 degrees Celsius (35 to 47 degrees Fahrenheit).
Viruses are kept cold for the same reason we refrigerate food items. “You wouldn’t take a steak and leave it out on your counter for any length of time and then eat it,” said Caryn Heldt, director of the Health Research Institute at Michigan Technological University and professor of chemical engineering. “A steak has the same stability issues — it has proteins, fats, and other molecules that, in order to keep them stable, we need to keep them cold.”
Like proteins, viruses unfold when it’s hot or there’s space to move around. Heat provides energy for viruses to shake themselves apart, and not being crowded gives them the room to fall apart. Stable vaccines need cold or crowding.
But what if cold storage isn’t available? What if someone accidentally leaves the package on the counter? What if the power goes out?
Heldt, together with Sarah Perry, professor of chemical engineering at the University of Massachusetts Amherst, has developed a way to mimic the body’s environment in vaccines using a process called complex coacervation. Rather than relying on refrigeration, Perry and Heldt tap the other method to keep viruses stable — crowding.
To keep the viruses in vaccines stable, everyone along the supply chain, from manufacturing facility to shipping company to doctor’s office, must maintain the cold temperature. This cooperative effort is known as the cold chain. If a vaccine is kept above that temperature range for even an hour, it may become ruined and unusable.
The World Health Organization estimates that up to 50% of vaccines are wasted every year because the cold chain and ideal temperature for storage cannot be maintained.
The human body is a crowded place. Cells of varying shapes and sizes jockey for position. This includes viruses, which do their nefarious work by hostile takeover. Viruses invade our cells, commandeering them to replicate. Unchecked, virus copies explode out of the cells like darts through a balloon. Then all of those replicas go and do the same to other cells — and before you know it, you’re sick.
Heldt researches vaccine manufacturing techniques and the COVID-19 pandemic has served as a masterclass. But SARS-CoV-2 isn’t the only virus in the world — there is still need for other vaccines and storage methods that don’t rely on refrigeration.
“The conditions for a vaccine that make it good to be injected into someone’s body are almost the opposite of what makes a virus stable,” Heldt said. “There’s a really hard trade-off of keeping the virus stable to get good immune response, while having the right components in the vaccine that are safe to inject.”
Heldt and Perry use polypeptides — synthetic proteins — that have positive or negative charges. When these charged peptides are put in solution, they stick together and form a separate liquid phase, a process called complex coacervation. The liquid wraps around virus capsids, holding the virus material together like a burrito’s tortilla.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Feed has no items.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- More Sinopharm vaccines arrive in Sri Lankaon July 2, 2021 at 6:32 pm
Health workers get ready to give Sinopharm vaccine in Colombo, Sri Lanka on July 2 2021. (Photo by Gayan Sameera/Xinhua) The Sinopharm vaccine arrived in Sri Lanka from China were handed to the Health ...
- 12 lessons COVID-19 taught us about developing vaccines during a pandemicon July 2, 2021 at 1:51 pm
The extraordinary drive to develop COVID-19 vaccines was like a moonshot — and like that fabled acceleration of space exploration science, it delivered. Just a little over six months after the first ...
- UL gets WHO accreditation, will test refrigerators for COVID-19 and other vaccineson July 2, 2021 at 12:24 pm
UL has announced that its Performance Laboratory in Gavirate received World Health Organization (WHO) accreditation as a designated third-party testing laboratory for refrigeration equipment, ...
- Vaccine Logistics: Technological Solutions Necessary for Fighting Covid on a Global Scaleon July 2, 2021 at 10:30 am
AstraZeneca, Pfizer, Covishield — the names that instill hope. The battle against the pandemic is on, and scientific labs ...
- UL Helps Refrigeration Manufacturers Meet COVID-19 Vaccination Storage Demand with World Health Organization Accreditationon July 2, 2021 at 6:15 am
With the surge in the need for vaccine storage, UL's World Health Organization accredited testing helps European refrigeration manufacturers ...